Xu Can-Xin, Lee Tae-Jin, Sakurai Nagisa, Krchma Karen, Liu Fang, Li Daofeng, Wang Ting, Choi Kyunghee
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
The People's Hospital of Hunan Province and Hunan Normal University Institute for Clinical and Translational Science, Changsha, Hunan 410006, China.
J Exp Med. 2017 Jun 5;214(6):1643-1653. doi: 10.1084/jem.20160923. Epub 2017 May 1.
Recent studies have established that hematopoietic stem cells (HSCs) are quiescent in homeostatic conditions but undergo extensive cell cycle and expansion upon bone marrow (BM) transplantation or hematopoietic injury. The molecular basis for HSC activation and expansion is not completely understood. In this study, we found that key developmentally critical genes controlling hematopoietic stem and progenitor cell (HSPC) generation were up-regulated in HSPCs upon hematopoietic injury. In particular, we found that the ETS transcription factor Ets variant 2 (; also known as ) was up-regulated by reactive oxygen species in HSPCs and was necessary in a cell-autonomous manner for HSPC expansion and regeneration after BM transplantation and hematopoietic injury. We found to be downstream of ETV2. As such, lentiviral expression rescued -deficient HSPC proliferation defects in vitro and in short-term BM transplantation in vivo. These findings demonstrate that is an important regulator of hematopoietic regeneration.
最近的研究表明,造血干细胞(HSCs)在稳态条件下处于静止状态,但在骨髓(BM)移植或造血损伤后会经历广泛的细胞周期和增殖。HSC激活和增殖的分子基础尚未完全了解。在本研究中,我们发现控制造血干细胞和祖细胞(HSPC)生成的关键发育关键基因在造血损伤后的HSPC中上调。特别是,我们发现ETS转录因子Ets变体2(;也称为)在HSPC中被活性氧上调,并且在BM移植和造血损伤后以细胞自主方式对HSPC增殖和再生是必需的。我们发现是ETV2的下游。因此,慢病毒表达挽救了体外和体内短期BM移植中缺陷的HSPC增殖缺陷。这些发现表明是造血再生的重要调节因子。